As our data as well as previous literature suggest PLK1 may play a pathogenic role in ACC, we examined the ability of two PLK1i (multi-targeting RGS and PBD-specific Pol) to block ACC cell proliferation and survival. The gene discussed is PITX2; the disease is adrenal cortex carcinoma.